Hyloris Pharmaceuticals SaEURONEXT: HYL

Consolidated 2025 Half-Year Results and Outlook: Hyloris Achieves Strong Royalty Growth and Portfolio Expansion with Solid Cash Position

Sep 25, 2025 at 5:14 AM UTC · Issued by Hyloris Pharmaceuticals SA

25 Sep 2025 07:06 CEST

Issuer

HYLORIS PHARMACEUTICALS SA

pr-half-year-results-2025en-final0.pdf

Source

HYLORIS

Provider

Euronext

Company Name

HYLORIS

ISIN

BE0974363955

Symbol

HYL

Market

Euronext